0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hypercholesterolemia Drug"

From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$2,999USDGBP
From
EUR$7,950USDGBP
Hypercholesterolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypercholesterolemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$4,850USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Hypercholesterolemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hypercholesterolemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 1282 Pages
  • Global
From
EUR$2,500USDGBP
From
EUR$5,600USDGBP
From
EUR$1,500USDGBP
From
EUR$4,950USDGBP
From
EUR$7,500USDGBP
From
EUR$3,950USDGBP
Familial Hypercholesterolemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Familial Hypercholesterolemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Hypercholesterolemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypercholesterolemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$4,150USDGBP
Loading Indicator

The Hypercholesterolemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of high cholesterol levels. Hypercholesterolemia drugs are used to reduce the amount of cholesterol in the blood, which can help reduce the risk of heart attack and stroke. These drugs are typically prescribed to patients with high cholesterol levels, or those at risk of developing cardiovascular disease. Commonly prescribed drugs include statins, bile acid sequestrants, fibrates, and cholesterol absorption inhibitors. The Hypercholesterolemia Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, AstraZeneca, Novartis, and Bristol-Myers Squibb. Show Less Read more